Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jacobs Solutions (J) Asset Writedowns and Impairment: 2021-2024

Historic Asset Writedowns and Impairment for Jacobs Solutions (J) over the last 2 years, with Sep 2024 value amounting to $3.0 million.

  • Jacobs Solutions' Asset Writedowns and Impairment fell 70.10% to $3.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $24.0 million, marking a year-over-year decrease of 50.10%. This contributed to the annual value of $3.0 million for FY2024, which is 93.77% down from last year.
  • According to the latest figures from Q3 2024, Jacobs Solutions' Asset Writedowns and Impairment is $3.0 million, which was down 70.10% from $10.0 million recorded in Q3 2023.
  • Over the past 5 years, Jacobs Solutions' Asset Writedowns and Impairment peaked at $72.3 million during Q4 2021, and registered a low of $914,000 during Q2 2023.
  • In the last 3 years, Jacobs Solutions' Asset Writedowns and Impairment had a median value of $3.7 million in 2022 and averaged $8.2 million.
  • Per our database at Business Quant, Jacobs Solutions' Asset Writedowns and Impairment spiked by 339.13% in 2023 and then tumbled by 70.10% in 2024.
  • Over the past 4 years, Jacobs Solutions' Asset Writedowns and Impairment (Quarterly) stood at $72.3 million in 2021, then slumped by 62.44% to $27.1 million in 2022, then spiked by 171.72% to $10.0 million in 2023, then tumbled by 70.10% to $3.0 million in 2024.
  • Its Asset Writedowns and Impairment was $3.0 million in Q3 2024, compared to $10.0 million in Q3 2023 and $914,000 in Q2 2023.